For patients with lymphoma there are many adverse health complications that arise in direct response to the disease as well as the treatments. Often, when treating for lymphoma, the complication may develop in response to the therapy that is used to regress the lymphoma.
A common complication among lymphoma patients involves a condition commonly referred to as being cutaneous. While may cutaneous complications resolves without need for any additional treatment, when the side effect of lymphoma treatment is progressive, re-appears, or is still present following the second therapy, your physician may wish to offer some treatment options.
If your physician has diagnosed your cutaneous complication as a concern during the treatment for your lymphoma, it is important to ask about the treatment options available for this health complication. For many patients, the physician will prescribe prescription Zolinza. As a once-per-day dosing formula, usually at 400 milligram doses, we often find the therapy used for Zolinza is quite effective in lymphoma patients.
As with any FDA approved prescription medication, the use of Zolinza will come with some side effects. However, in many cases, these side effects are similar to that often experience with lymphoma treatment and therapy. Side effects most commonly experienced with Zolinza include vomiting, diarrhea, nausea, and even abnormal blood glucose levels. For this reason, if your physician has prescribed Zolinza as part of your total lymphoma treatment, be certain you are prepared for these potential side effects.
As a Category D prescription drug, the use of Zolinza is not recommended in the treatment of cutaneous complication in pregnant women with lymphoma. Because the use of Zolinza is found to cause some abnormal fetal development, it is not recommended even in women of child bearing age.
Because Zolinza can create a complication involving electrolyte imbalance, it is important to drink plenty of water while using Zolinza. In fact, most patients using Zolinza should consume, at least, two liters of water per day.
As with any form of treatment involving lymphoma, it is important to remain compliant as this will offer the most optimal health outcome. Because lymphoma treatment and therapy can lead to cutaneous complications, your physician may need to prescribe additional medications to offset this side effect. When suffering from cutaneous complications, especially that which is recurrent, ask your physician about the use of prescription Zolinza. With a once-per-day dosing formula, this adverse health risk associated with lymphoma can be effectively managed.